Letter: should HCV cirrhotics with high bilirubin or Gilbert's syndrome be excluded from paritaprevir, ombitasvir, or dasabuvir?. Issue 9 (May 2016)

Record Type:
Journal Article
Title:
Letter: should HCV cirrhotics with high bilirubin or Gilbert's syndrome be excluded from paritaprevir, ombitasvir, or dasabuvir?. Issue 9 (May 2016)
Main Title:
Letter: should HCV cirrhotics with high bilirubin or Gilbert's syndrome be excluded from paritaprevir, ombitasvir, or dasabuvir?
Authors:
Madonia, S.
Orlando, E.
Stagno, B.
Cannizzaro, M.
Madonia, G.
Cottone, M.
Abstract:
Is Part Of:
Alimentary pharmacology & therapeutics. Volume 43:Issue 9(2016)
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 43:Issue 9(2016)
Issue Display:
Volume 43, Issue 9 (2016)
Year:
2016
Volume:
43
Issue:
9
Issue Sort Value:
2016-0043-0009-0000
Page Start:
1021
Page End:
1022
Publication Date:
2016-05
Subjects:
Digestive organs -- Diseases -- Treatment -- Periodicals
Digestive organs -- Effect of drugs on -- Periodicals
Gastrointestinal system -- Diseases -- Treatment -- Periodicals
Gastrointestinal system -- Effect of drugs on -- Periodicals
615.73
Journal URLs:
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2036 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:
10.1111/apt.13574 ↗
Languages:
English
ISSNs:
0269-2813
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 0787.886000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
774.xml